PharmaMar
Manufacturing · Spain · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
Avda. De Los Reyes 1pol, Colmenar Viejo,...Phone Number
+34 918466000Website
www.pharmamar.comRevenue
$171.4 MillionStock Symbol
PHMIndustry
About PharmaMar
Founded in 1986, PharmaMar a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, the rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and ovarian cancer; and Aplidin for treating multiple myeloma. The company also develops clinical-stage programs, including Lurbinectedin, PM184, and PM14. Also, it develops and markets diagnostics kits; and develops drugs with therapeutic activity based on reducing or silencing gene expression. The company is headquartered in Madrid, Spain.Explore more
PharmaMar Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
PharmaMar Tech Stack
A closer look at the technologies used by PharmaMar
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding PharmaMar
Sign Up For FreeTo access detailed company insights
Founded in 1986, PharmaMar a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, the rest of Europe, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and com... Read More
